Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

95 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Low rate of mother-to-child transmission of HIV-1 after nevirapine intervention in a pilot public health program in Yaoundé, Cameroon.
Ayouba A, Tene G, Cunin P, Foupouapouognigni Y, Menu E, Kfutwah A, Thonnon J, Scarlatti G, Monny-Lobé M, Eteki N, Kouanfack C, Tardy M, Leke R, Nkam M, Nlend AE, Barré-Sinoussi F, Martin PM, Nerrienet E; Yaoundé European Network for the Study of In Utero Transmission of HIV-1. Ayouba A, et al. Among authors: kouanfack c. J Acquir Immune Defic Syndr. 2003 Nov 1;34(3):274-80. doi: 10.1097/00126334-200311010-00003. J Acquir Immune Defic Syndr. 2003. PMID: 14600571 Clinical Trial.
Effectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine, and lamivudine in HIV-1-infected adults in Cameroon: open-label multicentre trial.
Laurent C, Kouanfack C, Koulla-Shiro S, Nkoué N, Bourgeois A, Calmy A, Lactuock B, Nzeusseu V, Mougnutou R, Peytavin G, Liégeois F, Nerrienet E, Tardy M, Peeters M, Andrieux-Meyer I, Zekeng L, Kazatchkine M, Mpoudi-Ngolé E, Delaporte E. Laurent C, et al. Among authors: kouanfack c. Lancet. 2004 Jul 3-9;364(9428):29-34. doi: 10.1016/S0140-6736(04)16586-0. Lancet. 2004. PMID: 15234853 Clinical Trial.
Antiretroviral drug resistance and routine therapy, Cameroon.
Laurent C, Kouanfack C, Vergne L, Tardy M, Zekeng L, Noumsi N, Butel C, Bourgeois A, Mpoudi-Ngolé E, Koulla-Shiro S, Peeters M, Delaporte E. Laurent C, et al. Among authors: kouanfack c. Emerg Infect Dis. 2006 Jun;12(6):1001-4. doi: 10.3201/eid1206.050860. Emerg Infect Dis. 2006. PMID: 16707062 Free PMC article.
Low levels of antiretroviral-resistant HIV infection in a routine clinic in Cameroon that uses the World Health Organization (WHO) public health approach to monitor antiretroviral treatment and adequacy with the WHO recommendation for second-line treatment.
Kouanfack C, Montavon C, Laurent C, Aghokeng A, Kenfack A, Bourgeois A, Koulla-Shiro S, Mpoudi-Ngole E, Peeters M, Delaporte E. Kouanfack C, et al. Clin Infect Dis. 2009 May 1;48(9):1318-22. doi: 10.1086/597779. Clin Infect Dis. 2009. PMID: 19320592
Risk factors for HIV-associated neurocognitive disorders (HAND) in sub-Saharan Africa: the case of Yaoundé-Cameroon.
Njamnshi AK, Bissek AC, Ongolo-Zogo P, Tabah EN, Lekoubou AZ, Yepnjio FN, Fonsah JY, Kuate CT, Angwafor SA, Dema F, Njamnshi DM, Kouanfack C, Djientcheu Vde P, Muna WF, Kanmogne GD. Njamnshi AK, et al. Among authors: kouanfack c. J Neurol Sci. 2009 Oct 15;285(1-2):149-53. doi: 10.1016/j.jns.2009.06.043. Epub 2009 Jul 24. J Neurol Sci. 2009. PMID: 19631349 Free PMC article.
Hepatotoxicity and effectiveness of a Nevirapine-based antiretroviral therapy in HIV-infected patients with or without viral hepatitis B or C infection in Cameroon.
Mbougua JB, Laurent C, Kouanfack C, Bourgeois A, Ciaffi L, Calmy A, Gwet H, Koulla-Shiro S, Ducos J, Mpoudi-Ngolé E, Molinari N, Delaporte E. Mbougua JB, et al. Among authors: kouanfack c. BMC Public Health. 2010 Mar 1;10:105. doi: 10.1186/1471-2458-10-105. BMC Public Health. 2010. PMID: 20193053 Free PMC article.
95 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page